|

HPC Offered for PRESERVE Expansion

RECRUITINGSponsored by Ossium Health, Inc.
Actively Recruiting
SponsorOssium Health, Inc.
Started2024-06-27
Est. completion2027-08
Eligibility
Age12 Years – 80 Years
Healthy vol.Accepted
Locations4 sites
View on ClinicalTrials.gov →

NCT07145411

Summary

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product

Eligibility

Age: 12 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

Patients aged 12-80 may be eligible\* to receive bone marrow for transplantation through the Ossium HOPE Program if:

Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outweighs the potential risks

Conditions2

Bone Marrow Transplant (BMT)Cancer

Locations4 sites

Alabama

1 site
University of Alabama, Birmingham
Birmingham, Alabama, 35294
Mary Underwood

Michigan

1 site
Henry Ford Health
Detroit, Michigan, 48202
Kelly Walls

Ohio

1 site
The Ohio State University Medical Center
Columbus, Ohio, 43210
Nicole Szuminski

Tennessee

1 site
Tristar Centennial Medical Center
Nashville, Tennessee, 37203
Angela Heine

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.